Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β
Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams
Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams
View: Text | PDF
Research Article Endocrinology Immunology

Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β

  • Text
  • PDF
Abstract

Glucocorticoid synthesis by adrenal glands (AGs) is regulated by the hypothalamic-pituitary-adrenal axis to facilitate stress responses when the host is exposed to stimuli. Recent studies implicate macrophages as potential steroidogenic regulators, but the molecular mechanisms by which AG macrophages exert such influence remain unclear. In this study, we investigated the role of AG macrophages in response to cold challenge or atherosclerotic inflammation as physiologic models of acute or chronic stress. Using single-cell RNA sequencing, we observed dynamic AG macrophage polarization toward classical activation and lipid-associated phenotypes following acute or chronic stimulation. Among transcriptional alterations induced in macrophages, triggering receptor expressed on myeloid cells 2 (Trem2) was highlighted because of its upregulation following stress. Conditional deletion of macrophage Trem2 revealed a protective role in stress responses. Mechanistically, Trem2 deletion led to increased AG macrophage death, abolished the TGF-β–producing capacity of AG macrophages, and resulted in enhanced glucocorticoid production. In addition, enhanced glucocorticoid production was replicated by blockade of TGF-β signaling. Together, these observations suggest that AG macrophages restrict steroidogenesis through Trem2 and TGF-β, which opens potential avenues for immunotherapeutic interventions to resolve stress-related disorders.

Authors

Yingzheng Xu, Michael T. Patterson, Bastien Dolfi, Alisha Zhu, Adeline Bertola, Patricia R. Schrank, Alexandre Gallerand, Ainsley E. Kennedy, Hannah Hillman, Lynn Dinh, Sia Shekhar, Samuel Tollison, Tyler D. Bold, Stoyan Ivanov, Jesse W. Williams

×

Figure 5

Macrophage Trem2 suppresses steroidogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Macrophage Trem2 suppresses steroidogenesis.
(A) Feature plot showing Tr...
(A) Feature plot showing Trem2 expression in macrophages across treatment groups. (B) Proportion of Trem2-expressing AG macrophages in treatment groups. (C) Histogram showing Trem2 expression distribution in macrophage subclusters. (D) Serum corticosterone in WT or Trem2–/– mice after 48 hours of cold housing. WT, n = 5. Trem2–/–, n = 6. Significance determined by Student’s t test, *P < 0.05. (E) Experimental design of atherosclerosis induction in Trem2-deficient mice fed TAM-HFD for 8 weeks. (F) Serum corticosterone in WT (n = 8), Trem2–/– (n = 7), CX3CR1creER Trem2WT Ldlr–/– (Trem2WT Athero, n = 9), or CX3CR1creER Trem2fl Ldlr–/– (MacrophageTrem2Δ Athero, n = 4) mice. Significance determined by ANOVA, **P < 0.005, ****P < 0.0001. (G) Flow cytometry quantification of AG macrophage lipid content (Bodipy). Trem2WT: atherosclerotic CX3CR1creER Trem2WT Ldlr–/– mice, n = 5. MacrophageTrem2Δ: atherosclerotic CX3CR1creER Trem2fl Ldlr–/– mice, n = 6. Significance determined by Student’s t test, **P < 0.005. (H) Serum corticosterone in CCR2creER Trem2WT mice or CCR2creER Trem2fl mice. n = 8 for each group. Significance determined by Student’s t test, *P < 0.05. (I) In vitro BV2-Y1 coculture experiment schematic. Y1 cells were assessed for StAR expression and normalized to control. n = 6 in each group, except n = 5 for Y1 ACTH–. Significance determined by Student’s t test, **P < 0.005. (J) Corticosterone concentration in coculture supernatant. Blue: Y1 cocultured with WT BV2. Green: Y1 cocultured with Trem2–/– BV2. n = 6 in each group, except n = 5 for Y1 + BV2WT ACTH–. Significance determined by 1-way ANOVA, *P < 0.05, **P < 0.005, ****P < 0.0001. Panels D and F–J are presented as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts